Physician profile
Scott Nottingham
NPI 1386685782
$998.52
in general payments reported to CMS, 2019-2025
17 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $399 · 2024: $400 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $998.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $135.29 | 2023 | |
| Seqirus USA INC | $120.41 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Neurelis, INC. | $112.22 | 2023-2024 | Valtoco |
| Phadia US INC. | $98.22 | 2024 | Immunocap |
| Qol Medical, LLC | $90.10 | 2024 | Sucraid |
| Pfizer INC. | $78.86 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $62.86 | 2025 | Jornay Pm |
| Ironshore Pharmaceuticals INC. | $52.84 | 2024 | |
| Glaxosmithkline, LLC. | $47.93 | 2023-2024 | Bexsero |
| Alk-Abello, INC | $43.68 | 2025 | Neffy |
| Corium, LLC | $36.67 | 2023-2024 | Azstarys |
| Cranial Technologies, INC | $27.99 | 2024 | Doc Band |
| Tris Pharma INC | $22.37 | 2024 | Dyanavel Xr |
| Sanofi Pasteur INC. | $20.11 | 2023 | |
| Kyowa Kirin, INC. | $19.50 | 2023 | Crysvita |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.87 | 2023 | Qelbree |
| Neos Therapeutics, LP | $13.60 | 2025 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Nottingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.